Human truncated tau is using a different mechanism from amyloid-β to damage the blood-brain barrier

Andrej Kovac, Monika Zilkova, M. Deli, Norbert Zilka, Michal Novak

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Recent findings showed that vascular dysfunction is an integral part of Alzheimer's disease pathology. Increased microvascular permeability is mainly associated with cerebrovascular amyloid-β deposits. In contrast, little is known about the relationship between functional impairment of the blood-brain barrier and misfolded tau. In the present study, we examined whether human truncated tau is able to impair the blood-brain barrier in an in vitro model. We have found that truncated tau induced a very strong polarity-dependent effect in the rat blood-brain barrier model. When the tau was added to the upper compartment of the model containing endothelial cells (apical treatment), no effect was observed. However, the application of tau to the lower compartment (basolateral treatment), consisting of astrocyte-microglia culture, triggered significant decrease of transendothelial electrical resistance and increase of endothelial permeability for mannitol. Further, we found that truncated tau showed cytotoxic effects on astrocyte-microglia culture manifested by increased extracellular adenylate kinase levels. Molecular analysis of underlying mechanisms of tau-induced blood-brain barrier damage revealed the contribution of pro-inflammatory cytokine tumor necrosis factor-α and chemokine MCP-1 released from activated microglial cells. This study for the first time uncovers a novel toxic gain of function of misfolded tau that could contribute to the cerebral microvascular damage in human tauopathies.

Original languageEnglish
Pages (from-to)897-906
Number of pages10
JournalJournal of Alzheimer's Disease
Volume18
Issue number4
DOIs
Publication statusPublished - 2009

Fingerprint

Blood-Brain Barrier
Amyloid
Microglia
Astrocytes
Tauopathies
Adenylate Kinase
Poisons
Amyloid Plaques
Capillary Permeability
Mannitol
Electric Impedance
Chemokines
Blood Vessels
Permeability
Alzheimer Disease
Endothelial Cells
Tumor Necrosis Factor-alpha
Pathology
Cytokines

Keywords

  • Alzheimer's disease
  • Blood-brain barrier
  • Microglia
  • Truncated tau protein
  • Tumor necrosis factor-α (TNF-α)

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Geriatrics and Gerontology
  • Clinical Psychology

Cite this

Human truncated tau is using a different mechanism from amyloid-β to damage the blood-brain barrier. / Kovac, Andrej; Zilkova, Monika; Deli, M.; Zilka, Norbert; Novak, Michal.

In: Journal of Alzheimer's Disease, Vol. 18, No. 4, 2009, p. 897-906.

Research output: Contribution to journalArticle

Kovac, Andrej ; Zilkova, Monika ; Deli, M. ; Zilka, Norbert ; Novak, Michal. / Human truncated tau is using a different mechanism from amyloid-β to damage the blood-brain barrier. In: Journal of Alzheimer's Disease. 2009 ; Vol. 18, No. 4. pp. 897-906.
@article{8fed8bf2794648b4b727045701e07cd8,
title = "Human truncated tau is using a different mechanism from amyloid-β to damage the blood-brain barrier",
abstract = "Recent findings showed that vascular dysfunction is an integral part of Alzheimer's disease pathology. Increased microvascular permeability is mainly associated with cerebrovascular amyloid-β deposits. In contrast, little is known about the relationship between functional impairment of the blood-brain barrier and misfolded tau. In the present study, we examined whether human truncated tau is able to impair the blood-brain barrier in an in vitro model. We have found that truncated tau induced a very strong polarity-dependent effect in the rat blood-brain barrier model. When the tau was added to the upper compartment of the model containing endothelial cells (apical treatment), no effect was observed. However, the application of tau to the lower compartment (basolateral treatment), consisting of astrocyte-microglia culture, triggered significant decrease of transendothelial electrical resistance and increase of endothelial permeability for mannitol. Further, we found that truncated tau showed cytotoxic effects on astrocyte-microglia culture manifested by increased extracellular adenylate kinase levels. Molecular analysis of underlying mechanisms of tau-induced blood-brain barrier damage revealed the contribution of pro-inflammatory cytokine tumor necrosis factor-α and chemokine MCP-1 released from activated microglial cells. This study for the first time uncovers a novel toxic gain of function of misfolded tau that could contribute to the cerebral microvascular damage in human tauopathies.",
keywords = "Alzheimer's disease, Blood-brain barrier, Microglia, Truncated tau protein, Tumor necrosis factor-α (TNF-α)",
author = "Andrej Kovac and Monika Zilkova and M. Deli and Norbert Zilka and Michal Novak",
year = "2009",
doi = "10.3233/JAD-2009-1197",
language = "English",
volume = "18",
pages = "897--906",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "4",

}

TY - JOUR

T1 - Human truncated tau is using a different mechanism from amyloid-β to damage the blood-brain barrier

AU - Kovac, Andrej

AU - Zilkova, Monika

AU - Deli, M.

AU - Zilka, Norbert

AU - Novak, Michal

PY - 2009

Y1 - 2009

N2 - Recent findings showed that vascular dysfunction is an integral part of Alzheimer's disease pathology. Increased microvascular permeability is mainly associated with cerebrovascular amyloid-β deposits. In contrast, little is known about the relationship between functional impairment of the blood-brain barrier and misfolded tau. In the present study, we examined whether human truncated tau is able to impair the blood-brain barrier in an in vitro model. We have found that truncated tau induced a very strong polarity-dependent effect in the rat blood-brain barrier model. When the tau was added to the upper compartment of the model containing endothelial cells (apical treatment), no effect was observed. However, the application of tau to the lower compartment (basolateral treatment), consisting of astrocyte-microglia culture, triggered significant decrease of transendothelial electrical resistance and increase of endothelial permeability for mannitol. Further, we found that truncated tau showed cytotoxic effects on astrocyte-microglia culture manifested by increased extracellular adenylate kinase levels. Molecular analysis of underlying mechanisms of tau-induced blood-brain barrier damage revealed the contribution of pro-inflammatory cytokine tumor necrosis factor-α and chemokine MCP-1 released from activated microglial cells. This study for the first time uncovers a novel toxic gain of function of misfolded tau that could contribute to the cerebral microvascular damage in human tauopathies.

AB - Recent findings showed that vascular dysfunction is an integral part of Alzheimer's disease pathology. Increased microvascular permeability is mainly associated with cerebrovascular amyloid-β deposits. In contrast, little is known about the relationship between functional impairment of the blood-brain barrier and misfolded tau. In the present study, we examined whether human truncated tau is able to impair the blood-brain barrier in an in vitro model. We have found that truncated tau induced a very strong polarity-dependent effect in the rat blood-brain barrier model. When the tau was added to the upper compartment of the model containing endothelial cells (apical treatment), no effect was observed. However, the application of tau to the lower compartment (basolateral treatment), consisting of astrocyte-microglia culture, triggered significant decrease of transendothelial electrical resistance and increase of endothelial permeability for mannitol. Further, we found that truncated tau showed cytotoxic effects on astrocyte-microglia culture manifested by increased extracellular adenylate kinase levels. Molecular analysis of underlying mechanisms of tau-induced blood-brain barrier damage revealed the contribution of pro-inflammatory cytokine tumor necrosis factor-α and chemokine MCP-1 released from activated microglial cells. This study for the first time uncovers a novel toxic gain of function of misfolded tau that could contribute to the cerebral microvascular damage in human tauopathies.

KW - Alzheimer's disease

KW - Blood-brain barrier

KW - Microglia

KW - Truncated tau protein

KW - Tumor necrosis factor-α (TNF-α)

UR - http://www.scopus.com/inward/record.url?scp=74949115348&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74949115348&partnerID=8YFLogxK

U2 - 10.3233/JAD-2009-1197

DO - 10.3233/JAD-2009-1197

M3 - Article

VL - 18

SP - 897

EP - 906

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 4

ER -